Skip to main content
DB

Dash Bio

Dash operates as a bioanalysis Contract Research Organization (CRO) utilizing a tech-first approach to accelerate sample analysis turnaround times. The company offers comprehensive services including method development, validation, ELISA/MSD, LC-MS, and qPCR across preclinical and clinical stages. They provide transparent, fixed-price services with guaranteed results, supporting biopharma programs from early development through late-stage trials.

Boston, United StatesFounded 202410700+ followers
Updated 20 months ago

Funding

$6.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

FC
Funding rounds are not available yet.

Founders

Product

Problem

The drug development process is often slowed down by traditional bioanalysis methods, which are labor-intensive and can lead to delays in clinical trials and in vivo studies. These traditional methods struggle to keep pace with the rapid advancements in AI-powered drug discovery, creating a bottleneck in the overall development pipeline.

Solution

Dash Bio offers an automated bioanalysis platform designed to accelerate clinical assay development, validation, and sample analysis. By integrating robotics and AI, the platform significantly reduces turnaround times and improves the quality of results for both in vivo and clinical studies. The platform automates critical steps in the bioanalysis process, reducing manual labor and improving data flow. Dash Bio's approach ensures quality, regulatory compliance, and faster time to market for new drugs.

Target Audience

Dash Bio serves biotechnology, pharmaceutical companies, and contract research organizations (CROs) involved in drug development and clinical trials.

Features

  • Fully automated, GLP-compliant bioanalysis platform
  • AI-driven data analysis for improved accuracy and faster turnaround times
  • Robotic sample handling to minimize human error and increase throughput
  • Integrated system for assay development, validation, and sample analysis
  • Support for a range of bioanalytical assays, including LC-MS, ELISA, MSD, and PCR
  • Streamlined data flow from sample to report
This profile is AI-generated and may contain inaccuracies.